Life4me+ news story
At CROI 2026, an oral abstract session was dedicated to HIV PrEP. There were no revolutionary discoveries in this session, but something more important happened: experts gave a technically mature assessment of the state of prevention science in 2026.
The session, which included five interconnected presentations, highlighted two major points: the exceptional biological effectiveness of prevention drugs and emerging structural problems in their use.
Read the full news story here.
View all Life4me+ reports from CROI 2026
Source : Life4me+
Related HIV and Co-Infections News
-
[Press release] US and Global Fund expand commitment to long-acting HIV prevention as country rollout of lenacapavir accelerates
-
University of Manchester: Scientists develop a cheaper and more sustainable way to manufacture breakthrough HIV drug lenacapavir
-
EL PAÍS: US aid cuts collapse Malawi’s LGBTQ+ health services as volunteers scramble to fill the void
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.